Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MHC-I”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Looking for participantsNCT03882840
What this trial is testing

Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I

Who this might be right for
Anti-cancer Cell ImmunotherapyT Cell and NK Cell
Second Affiliated Hospital of Guangzhou Medical University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105021
What this trial is testing

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerColorectal Cancer+2 more
Affini-T Therapeutics, Inc. 100
Testing effectiveness (Phase 2)Ended earlyNCT02584829
What this trial is testing

Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Polyomavirus InfectionStage IV Merkel Cell Carcinoma AJCC v7
Fred Hutchinson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00002637
What this trial is testing

Biological Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 25
Not applicableStudy completedNCT06982937
What this trial is testing

Mechanistic Drivers of Acute PAPE Responsiveness: Muscle Architecture, Contractile Kinetics, and Excitability in a Randomized Controlled Trial

Who this might be right for
Neuromuscular FunctionMuscle ActivationPostactivation Potentiation+4 more
The Jerzy Kukuczka Academy of Physical Education in Katowice 44
Early research (Phase 1)Study completedNCT02289196
What this trial is testing

Safety Study of Vx006 Vaccine in Solid Tumor Patients

Who this might be right for
Solid Tumor
Vaxon Biotech 23
Very early researchEnded earlyNCT01957709
What this trial is testing

Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Myxoid LiposarcomaRound Cell LiposarcomaSynovial Sarcoma
Fred Hutchinson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00118274
What this trial is testing

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Craig L Slingluff, Jr 170
Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT02528682
What this trial is testing

MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT

Who this might be right for
Hematological Malignancies
Radboud University Medical Center 10
Early research (Phase 1)Study completedNCT02313857
What this trial is testing

Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)

Who this might be right for
CMV Infections
AlloVir 10
Testing effectiveness (Phase 2)Study completedNCT00048412
What this trial is testing

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

Who this might be right for
Myelodysplastic DisordersLeukemiaMultiple Myeloma+2 more
Baylor College of Medicine 40
Testing effectiveness (Phase 2)Ended earlyNCT02080195
What this trial is testing

Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Lupus ErythematosusGraft-versus-host Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03983850
What this trial is testing

Optimizing PTCy Dose and Timing

Who this might be right for
Graft Versus Host DiseaseHematologic Neoplasms
National Cancer Institute (NCI) 105
Testing effectiveness (Phase 2)Ended earlyNCT00048399
What this trial is testing

Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H

Who this might be right for
Graft Failure
Baylor College of Medicine 40
Early research (Phase 1)WithdrawnNCT02276820
What this trial is testing

Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)

Who this might be right for
Adenovirus Infection
AlloVir
Testing effectiveness (Phase 2)Ended earlyNCT00683085
What this trial is testing

Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreas Neoplasms
Tokyo University 2
Early research (Phase 1)Study completedNCT01462396
What this trial is testing

Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors

Who this might be right for
Neuroblastoma
Children's Mercy Hospital Kansas City 4
Not applicableStudy completedNCT02142764
What this trial is testing

Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
University Hospital, Bordeaux 30
Early research (Phase 1)WithdrawnNCT02313844
What this trial is testing

Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)

Who this might be right for
BK Virus Infection
AlloVir
Load More Results